AI Generated Image
Ozempic earlobes join growing list of cosmetic concerns from GLP-1 drugs
Fox News • • business
Key Points:
- The rising use of GLP-1 drugs like Ozempic for weight loss has led to increased cosmetic concerns, including "Ozempic earlobes," characterized by thinner, longer, or sagging earlobes due to fat loss in the area.
- Surgeons report a surge in body contouring procedures such as breast lifts, panniculectomies, abdominoplasties, arm lifts, and thigh lifts as patients seek to address excess skin and volume loss following rapid weight loss from GLP-1 drugs.
- Rapid fat loss from these medications can cause sagging and deflation in areas like the breasts and buttocks, with patients often requiring surgical or nonsurgical treatments to restore volume and tighten skin.
- Experts recommend adequate protein intake and resistance training during GLP-1-induced weight loss to help preserve lean muscle mass and potentially reduce some of the associated cosmetic side effects.
- Despite these cosmetic changes, semaglutides do not damage ear tissue or affect hearing, and interventions for "Ozempic earlobes" are purely aesthetic, involving options like dermal fillers, fat transfer, or surgical reduction.
